Possible relationship between refractory celiac disease and malignancies

doi:10.5306/wjco.v13.i3.200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2478)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

204

WORD

HTML

1325

Figures (1-1)

287

Tables (1-2)

138

Sum=2052

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

166

Download

260

Sum=426

Mar 24, 2022 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Mar 24, 2022; 13(3): 200-208
Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.200

Full Size Figure Download Figure

Figure 1 Properties of refractory celiac disease type 1, type 2 and enteropathy-associated T-cell lymphoma. RCeD: Refractory celiac disease; EATL: Enteropathy-associated T-cell lymphoma; IEL: Intraepithelial lymphocytes; TCR: T cell receptor.

Citation: Demiroren K. Possible relationship between refractory celiac disease and malignancies. World J Clin Oncol 2022; 13(3): 200-208
URL: https://www.wjgnet.com/2218-4333/full/v13/i3/200.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i3.200